Morningside Venture Investments Ltd, 10% Owner at Amylyx Pharmaceuticals, Inc. (AMLX), sold 18,244 shares at $32.55 ($594K) on 2023-03-16, disclosed to the SEC on 2023-03-17.
Open-market sale of $594k AMLX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.55 | 9,122 | $297K | 50.0% |
| 2 | $32.55 | 9,122 | $297K | 50.0% |
| Total | $32.55 avg | 18,244 | $594K | 100% |
| Filing → |
| AMLX | SELL | 2023-03-29 | $4.9M | — | Filing → |
| AMLX | SELL | 2023-03-23 | $4.0M | — | Filing → |
| AMLX | SELL | 2023-03-16 | $14.9M | — | Filing → |